These apparently conflicting data may be due to the multi-faceted immune responses associated with Th17 cells while IL-17A, as a unique cytokine, may reveal its effects depending on the tumor microenvironment and tumor histology32,34,35. This evidence concerns the gene IL17A and neoplasm.